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What does this study add: 
• This study is the first clinical investigation using electroencephalography for prediction of 
postoperative opioid analgesia.  
• The combined method of machine learning and electroencephalography offers promising results for 





Opioids are often used for pain treatment, but the response is often insufficient and dependent on e.g., the 
pain condition, genetic factors and drug class. Thus, there is an urgent need to identify biomarkers to enable 
selection of the appropriate drug for the individual patient, a concept known as personalized medicine. 
Quantitative sensory testing (QST) and clinical parameters can provide some guidance for response, but 
better and more objective biomarkers are urgently warranted. Electroencephalography (EEG) may be 
suitable since it assesses the central nervous system where opioids mediate their effects. 
Methods:  
Clinical parameters, QST and EEG (during rest and tonic pain) was recorded from patients the day prior to 
total hip replacement surgery. Postoperative pain treatment was performed using oxycodone and piritramide 
as patient-controlled analgesia. Patients were stratified into responders and non-responders based on pain 
ratings 24 hours post-surgery. Parameters were analysed using conventional group-wise statistical methods. 
Furthermore, EEG was analysed by machine learning to predict individual response. 
Results:  
Eighty-one patients were included, of which 51 responded to postoperative opioid treatment (30 non-
responders). Conventional statistics showed that more severe pre-existing chronic pain was prevalent among 
non-responders to opioid treatment (P=0.04). Preoperative EEG analysis was able to predict responders with 
an accuracy of 65% (P=0.009), but only during tonic pain. 
Conclusions 
Chronic pain grade before surgery is associated with the outcome of postoperative pain treatment. 
Furthermore, EEG shows potential as an objective biomarker and might be used to predict postoperative 
opioid analgesia. 
Significance 
Personalized pain medicine based on EEG has received limited attention within the field apart from a single 
experimental study. The current clinical study demonstrates the viability of EEG as a biomarker and with 





Opioids are the primary analgesic drugs used to treat moderate to severe pain, including pain after surgery 
(Liu and Wu, 2007). However, treatment of postoperative pain remains in many cases unsatisfactory, leading 
to unnecessary suffering (Dolin et al., 2002; Drewes et al., 2013; Maier et al., 2010; Sommer et al., 2008). 
Furthermore, inadequate analgesia carries the risk of developing persistent long-term pain (Gerbershagen et 
al., 2009; Kehlet et al., 2006; VanDenKerkhof et al., 2012). Better understanding of the inter-individual 
differences in pain processing is paramount to achieve improved and personalized opioid treatment (Bruehl 
et al., 2013). However, there is no method to determine if opioid treatment will provide analgesic relief in the 
postoperative setting. Some studies have focused on quantitative sensory testing (QST), but with 
contradictory results (Grosen et al., 2013). This indicates a need for improvement in the ability to accurately 
predict analgesic effect of opioids (Grosen et al., 2013). 
Pain processing can be investigated using imaging techniques such as magnetic resonance imaging 
(Ahmedzai, 2013). However, electroencephalography (EEG) is more clinically feasible to assess pain 
processing as it has a considerably lower cost and can be used directly at the patient’s bedside or in the 
outpatient clinic. Furthermore, EEG can assess inter-individual differences in pain processing by predicting 
the experience of pain within a single subject (Schulz et al., 2011). For instance, EEG recorded during rest 
was used to predict pain perception during experimentally induced pain (Nir et al., 2012) and in the clinic to 
asses analgesic efficacy (Graversen et al., 2012). We have previously shown that EEG during tonic pain is 
more reliable and superior than resting EEG for prediction of analgesic efficacy in healthy volunteers (Gram 
et al., 2014, 2015). The present study now aims to investigate EEG for prediction of analgesic efficacy in 
clinical population. 
We hypothesized that risk factors for analgesic inefficacy of postoperative opioid treatment could be 
identified preoperatively. Additionally, we hypothesized that EEG could be used as an objective biomarker 
for predicting analgesic efficacy. Thus, the aims of this study were to a) determine the effect of the 
postoperative pain treatment, b) investigate risk factors associated with non-response to analgesic treatment 
and c) predict the analgesic response based on the pre-operative EEG (during rest and tonic pain) on an 
individualized basis in patients undergoing hip replacement surgery. Unlike previous EEG prediction studies 
which used the spectral content within pre-defined frequency bands (Gram et al., 2015) to evaluate brain 
rhythmicity, we also applied a functional connectivity evaluation which considers the brain as a large inter-
connected network and investigates the interactions between different cortical regions (Hardmeier et al., 
2014).  We also applied machine learning methods which have the ability to assess the interaction between 




The study was conducted at the Pain Clinic, Center for Anesthesiology, Emergency and Intensive Care 
Medicine at the University Hospital Göttingen, Germany and the Orthopedic University Hospital of the 
Medical School Hannover, Germany. The study was approved by the Ethical committees of the University 




Patients admitted to the Orthopaedic University Hospital Annastift in Hannover for total hip replacement 
were recruited between April and August 2013.  
Inclusion criteria were patients above 18 years of age and able to give informed consent. Exclusion criteria 
were 1) severe neurological disease, which might interfere with the EEG recordings or experimental pain 
testing (including dementia); 2) Severe psychiatric disease such as major depression or schizophrenia or 
active drug abuse; 3) High dose of preoperative opioid therapy (> 30 mg/day oral morphine equivalent). In 
case of post-operative delirium making the subject unable to complete the study due to disorientation or 
inability to answer questionnaires, the subject was excluded.  
 
Study outcomes and risk factors 
Response to post-surgical analgesic treatment was assessed using a response score based on the results of 
patients outcomes assessed by the “Quality Improvement in Postoperative Pain Management” Questionnaire 
(QUIPS), which is a validated German outcome measurement instrument for post-operative quality control, 
see below (Meissner et al., 2008).  
Predictors for insufficient analgesic response were investigated and included clinical patient characteristics 
and standardized assessment of the preoperative pain symptoms, QST parameters, conditioned pain 
modulation (CPM) effect and EEG during rest and cold pain. Clinical patient data included age, sex and 
body mass index (BMI) while parameters on the preoperative pain condition included pain duration, chronic 
pain grade (Von Korff et al., 1992), Mainz Pain Staging System (MPSS) (Schmitt and Gerbershagen, 1990), 
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) (Bellamy, 2005) as well as pain 





Figure 1 shows the experimental setup. Patients were examined one day prior to their operation. Patients 
were told to refrain from smoking and from drinking coffee and other caffeine-containing beverages 2 hours 
prior to the clinical testing. 
All clinical testing were conducted between 15:00 and 18:00 on the preoperative day by the same examiner. 
The clinical testing commenced with familiarization of the cold pressor test and the experimental evoked 
pain conditions applied. Patients were placed on a bed in a semi-recumbent position, and the EEG cap was 
mounted on their head with conducting gel inserted for each electrode. Resting EEG was recorded followed 
by EEG recording during the cold pressor test. 
 
Perioperative pain management 
The patients preoperative pain medication (type and dosage) was noted and the Medication Quantification 
Score (MQS), which is a reliable and validated score for quantifying analgesics, was calculated in order to 
obtain a comparable metric for all different analgesics (Masters Steedman et al., 1992). It enables calculation 
characterization of analgesics when many analgesics are involved and doses are irregular, as is the case for 
the patient group in this study. It was calculated for each non-opioid and opioid based on weights assigned 
by medication class and dosage level (level 1 = sub-therapeutic dosage and/or on demand, level 2 = lower 
50% of the therapeutic dose range, level 3 = upper 50% of the therapeutic dose range, level 4 = supra-
therapeutic dose) using the 1998 detriment weights (Stormo, Kee, Steedham, & Middaugh, 1998). The 
detriment weights are summed by the dosage level to provide the final score. To provide a quantitative index 
for analgesics usage suitable for statistical analysis these scores were summed. 
In the evening before and morning prior to surgery, all patients were pre-medicated with 20-30mg 
dipotassium chlorazepat. General anaesthesia was performed according to the local clinical standards, with 
remifentanyl (1-1.5 µg/kg /3 min) and propofol (1-2 mg/kg). Orotracheal intubation was facilitated by 0.5 
mg/kg atracurium.  Propofol (3.5-4.5 mg/kg/h) and remifentanyl (0.15-0.25 μg/kg/min) were used for 
maintenance of anesthesia. During the implantation of the femoral shaft, intravenous injection of 0.1 mg/kg 
piritramide and 15 mg/kg metamizol (or paracetamol, if contra-indicated) were administered.  
In the recovery phase, patients received 10 or 20 mg slow-release oxycodone (10 mg if their weight was 
below 60 kg and age above 70 years, otherwise 20 mg was given) along with 600 mg ibuprofen. Pain was 
titrated using intravenous piritramide bolus application of 3.75mg until pain intensity was 3 or below on a 
numerical rating scale (NRS; 0 = no pain und 10 = worst imaginable pain) (see section on pain assessments). 
Then patients received patient-controlled analgesia (PCA) with piritramide for 24 hours using piritramide 
5 
 
(Perfusor fm PCA, B. Braun; single dose 2 mg, lockout 10 min, limit 30 mg/4 hours) at a NRS of 3 or below 
and as soon as they were able to operate the PCIA system. On the ward, oxycodone (twice a day) and 
ibuprofen (three times a day) was administered according to the first dosage and followed a standardized 
post-operative pain treatment protocol (Erlenwein et al., 2012). 
Then the 24 hour opioid dose was calculated as oral morphine equivalent (ME; conversion factor to 
morphine: piritramide 1.5, hydromorphone 0.13, oxycodone 0.75, intravenous vs. oral morphine 3:1). 
Chronic pain assessments  
Before surgery, patients indicated their duration of pain, and their chronic pain grade was assessed (Von 
Korff et al., 1992). This grading system divides patients into four grades of chronic pain based on their pain 
intensity and disability, which can be summarized as: 
• Grade I:  low pain intensity, low disability 
• Grade II:  high pain intensity, low disability 
• Grade III: high disability – moderately limiting 
• Grade IV: high disability – severely limiting 
The chronic pain grades I and II are based on the pain intensity, but only for patients with a low disability 
following their pain. Grades III and IV consists of patients with a certain degree of disability from their pain, 
and therefore disregards the pain intensity, but solely looks at how limiting the pain is (Von Korff et al., 
1992).  
Furthermore, the clinician assessed the patient’s pain profile using the Mainz Pain Staging System (MPSS), 
which divides patients into three pain stages of increasing  pain chronicity (Frettlöh et al., 2003; Schmitt and 
Gerbershagen, 1990). Passive hip rotation 
A test was performed to assess the magnitude of evoked pain with passive rotation of the hip scheduled for 
replacement. First, the leg was brought into a 90° flexed position, with the knee flexed at 90° at the same 
time, and then slowly rotated interiorly until the patient reported the first onset of pain (pain detection 
threshold). Then, the passive rotation was continued until the pain threshold was reached and this position 
was maintained for 30 seconds. Afterwards the patients were asked to rate the evoked hip pain on a NRS.  
 
Quantitative sensory testing (QST) 
Perceived pain intensity was rated on a NRS. 
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Heat pain threshold 
Heat pain assessments were performed with 9cm2 Peltier Thermode, 10 cm proximal to the wrist of the right 
volar forearm, using a ‘Thermo Tester’ (TSA II NeuroSensory analyzer, Medoc Ltd, Ramat Yishai, 
Israel).The temperature was gradually increased from a baseline of 32°C baseline at a rate 1°Cs-1 to a 
maximum temperature of 52°C. The subjects were instructed to press a button when the heat stimulus 
became painful and this was documented as the heat pain threshold. Four consecutive assessments were 
performed and the average of the last three threshold estimations was retained for further analysis.  Cold pressor test 
Patients were instructed to submerge their non-dominant hand in water until the wrist was covered (~8 °C) 
and keep it submerged for 2 minutes. The temperature of the water was controlled. The maximum pain 
intensity perceived during the test was rated on a NRS. Conditioned pain modulation (CPM) 
A CPM paradigm was utilized to investigate the generation of descending pain modulation. The CPM can be 
measured by application of a test-stimulus (in this case heat pain threshold), during and following the 
application of a conditioning stimulus (in this case the cold pressor test). An increase of the pain threshold 
after application of the conditioning stimulus indicates the presence of descending pain modulation (Pud et 
al., 2009). 
In this study, heat pain threshold was repeated at 120 seconds after the cold pressor test was initiated. This 
was done to assess the conditioned pain modulation of each patient. The difference between the heat pain 
threshold at baseline and 120 seconds after initiation of the cold pressor test was determined and expressed 
as a percent to quantify the CPM effect. 
 
Post-operative pain 
The outcome quality of post-operative pain management was assessed with the QUIPS-questionnaire which 
is a validated German outcome measurement instrument for post-operative quality control, and the national 
register currently includes more than 400,000 patients from around 200 hospitals. It consists of three questions 
asking for 1) pain intensity during movement, and 2) the least and worst pain over the last 24 hours, all rated 
on the NRS. Furthermore, it includes 3) questions about patients´ pain intensity and postoperative functional 
restrictions (mobilization, coughing/deep breathing, night-sleep, yes/no) (W Meissner et al., 2006; Winfried 
Meissner et al., 2008). The first 24 hours were chosen since it was the most standardized period in the post-
surgery treatment, with some patients commencing rehabilitation after 24 hours, while other remained on 
bed-rest. The questionnaire is in German, but a translation of the questions to English is available (Winfried 
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Meissner et al., 2008). Hence, it  has served as model for the internationally used PAIN OUT questionnaire, 
which is available in various languages (R. Zaslansky et al., 2015; Ruth Zaslansky et al., 2014). 
Since there is no validated definition for a positive opioid response in a perioperative setting, we developed a 
“response score” to determine analgesic response after surgery based on various patient´s reported outcome-
items used in the QUIPS questionnaire. Points indicating an overall successful pain management were 
awarded up to a maximum of 10 by the following criteria: 
• Maximal pain NRS < 5: =  + 2 points 
• Pain on movement NRS < 5 = + 2 points 
• Minimum pain NRS < 3 = + 2 points 
• No pain on mobilization = + 1 point 
• No pain when coughing = + 1 point 
• No pain when waking up = + 1 point 
• No effect on mood = + 1 point 
Definition of cut off points was based on typical intervention thresholds for postoperative pain management 
(e.g. pain on movement or maximal pain of 5) (Maier et al., 2010; Rothaug et al., 2013). Interaction of pain 
with function was included to derive a clinically meaningful response. Patients with a score of 5 or higher 
were considered opioid responders, those with scores of 4 or lower non-responders to opioids. 
 
EEG recordings 
EEG was acquired using a 34-channel cap (34ch prewired cylindrical Ag/AgCl electrodes, MEQNordic A/S, 
Jyllinge, Denmark) and amplified on a Nuamp system (NuAmp, Neuroscan, El Paso, TX, USA) and 
recorded for later analysis. The cap was placed symmetrical in a standardized position 3 cm above the 
nasium. Electrode gel was applied into each of the recording channels to reduce the electrode impedance 
below 5 kΩ. Recordings were performed in a dimmed light room with all unnecessary electrical equipment 
turned off to avoid 50 Hz contaminations. Sampling frequency was 1000 Hz.  
First resting EEG was acquired and patients were instructed to minimize eye movements and refrain from 
talking. Open or closed eyes were alternated between in 4 sequences of 2.5 min, starting with eyes open. For 
this study, only the first recording of 2.5 min eyes open was used. 
EEG during the cold pressor test was commenced as soon as the patient immersed their hand into the water. 
The first 60 seconds of recording after hand immersion was used for analysis to avoid artefacts induced by 




The data was pre-processed with Neuroscan software (Neuroscan 4.5, Neuroscan, El Paso, TX, USA)  in the 
following steps: 1) zero-phase shift notch filtering (49–51 Hz) using a finite impulse-response filter with a 
slope of 24 dB/octave; 2) zero-phase shift band-pass filtering (1-80 Hz) using a finite impulse-response filter 
with a slope of 12 dB/octave; 3) blinded visual inspection of data quality for all channels using linked-ear 
reference. Channels with abnormal signals were discarded and replaced by signals interpolated from 
neighbouring electrodes; 4) Re-referencing to the average electrode. 
 
Spectral analysis 
Spectral indices were calculated using Matlab 2012a (The Mathworks, Inc., Natick, MA, USA) in order to 
obtain the relative EEG amplitude. Calculations were performed using a wavelet transform as this has a 
superior time-frequency resolution than the more common Fourier transform (Akin, 2002). The continuous 
wavelet transform was applied to EEG from each channel using the complex Morlet wavelet as a mother 
wavelet function with a bandwidth of 10 Hz and a center frequency of 1 Hz. Scales for the mother wavelet 
was chosen to match frequencies ranging from 1 to 32 Hz with a 0.5 Hz between-scale frequency interval. 
The absolute values of the obtained wavelet coefficients were used for analysis and divided into the 
following standardized frequency bands: delta (1 – 4 Hz), theta (4 – 8 Hz), alpha (8 – 12 Hz) and beta (12 – 
32 Hz). The wavelet coefficients were averaged over time and scales contained within each frequency band 
were summed together to yield the absolute activity within each frequency band. The relative activity was 
calculated separately for each channel by dividing each frequency band with the total energy of all bands and 
multiplying by 100. The values then represent the percentage of total amplitude contained in each frequency 
band. 
 
Functional connectivity analysis 
Functional connectivity is a new approach within EEG, but has been used within structural and functional 
magnetic resonance imaging (Hardmeier et al., 2014). Functional connectivity considers the brain as a 
complex network of inter-connected nodes (Hardmeier et al., 2014). Several methods exist for estimation of 
functional connectivity within EEG analysis and most methods work by investigating the phase-relationships 
between EEG signals for different electrodes, where electrodes with similar phases are thought to be 
exchanging information (Nolte et al., 2008). The phase-lag index (PLI) is based on a consistent lag between 
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instantaneous phases between two signals and thus ignores most zero-phase phase-relations in order to 
discard volume conduction noise (Nolte et al., 2008). 
The PLI was calculated for the same frequency bands as used for the spectral analysis, using the 
implementation from The Neurophysiological Biomarker Toolbox (NBT) (http://www.nbtwiki.net/). The 
signal was divided into time windows and the PLI was calculated for each window. Lastly, the results for all 
time windows were averaged. The window width was set to twice the sampling frequency (2000 samples) as 
this provides a frequency resolution of 0.5 Hz, which is equal to the spectral analysis. The band-pass filter 
was a 1st order butterworth filter (Lehembre et al., 2012). 
 
Machine learning analysis 
A support vector machine (SVM) was used for the machine learning approach. The SVM is a binary 
classifier which optimizes the decision threshold between two groups without any a priori assumptions about 
the data (Cortes and Vapnik, 1995). The SVM was chosen over other machine learning classifiers since it has 
previously been used for other prediction studies in pain medicine (Graversen et al., 2012; Olesen et al., 
2013a).  
To avoid over-fitting, the most discriminative features were selected using the criteria for joint mutual 
information, as this criterion has been found to provide the best selection for data sets with a limited number 
of samples (Brown et al., 2012). For both resting EEG and EEG during cold pain, features were selected 
using the joint mutual information criterion and subsequently used for SVM classification. The number of 
features to be used was determined by investigating the accuracy of the classifier by gradually increasing the 
number of features up to 15. Accuracy was defined as the ratio between correctly classified subjects and total 
number of subjects in percentage. The number of features that yielded the highest accuracy on both study 
days was chosen for the final analysis due to the importance of reliability in the classifier. Classification was 
performed using the libSVM toolbox (version 3.20) for Matlab (Chang and Lin, 2011). A linear kernel 
function was used to avoid over-fitting of the data (Gong et al., 2011). The cost parameter C of the SVM was 
set to 1. Classification accuracy was determined using leave-one-out cross-validation which consisted of 
removing one subject before performing feature selection and training the SVM classifier using all remaining 
subjects. The subject that was removed was then used to test the predictive capability of the classifier. This 
was repeated until all subjects had been left out, to assess the overall accuracy of the classifier (Gong et al., 
2011; Gram et al., 2015; Graversen et al., 2011). Accuracy, positive predictive value and negative predictive 
value of the classification were calculated. 
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Lastly, the feature selection method was applied to the complete dataset, in order to indicate which features 
were most useful for classification. 
 
Statistical analysis 
All data are reported as mean ± standard deviation unless otherwise stated. Logistic regression was used to 
determine the capability of different clinical variables to predict post-operative analgesia. Significant 
predictors in univariate analysis were included in a multivariate analysis and bootstrapping (1000 samples) 
was used for internal validation of the multivariate estimates. Analysis of Multichannel EEG was carried out 
using a mixed analysis of variance (ANOVA) model with electrode (i.e., electrode 1 through 34) as within-
subjects factor and responder group (i.e. responder vs. non-responder) as between-subjects factor. The F-test 
results were corrected for identity covariance matrix by the Greenhouse–Geisser method to take into account 
possible intragroup correlations. Additionally, data were analyzed using the previously described machine 
learning approach. SVM classifications were analysed using chi-square. P-values below 0.05 were 





Out of 175 patients screened for the study, 112 was eligible for the study and signed the informed consent 
(24 patients declined to participate, 1 was below 18 years of age, 1 was already participating in another 
study, 1 due to replacement of both hips in the same surgery, 1 because informed consent could not be 
obtained, 13 for planned spinal anaesthesia during surgery, 4 due to high preoperative opioid use, 1 due to 
drug abuse and 17 due to a history of neurological conditions). Out of the 112 patients who signed the 
informed consent, 81 were included in the final analysis (15 excluded because surgery was cancelled or 
consent was withdrawn, 3 because PCA was not administered, 1 due to postoperative delirium, 1 because of 
sevoflurane anaesthesia, 1 because of basal-bleeding history, 1 due to insufficient time to complete 
measurements and 9 patients for having one or more unusable EEG recordings due to poor quality). 
Demographics and clinical characteristics of the final 81 patients (36 males and 45 females) are reported in 
Table 1. 
Response to post-operative analgesic treatment 
Fifty-one patients (63%) were classified as opioid responders and 30 (37%) were classified as opioid non-
responders based on the response score from the QUIPS questionnaire. Details of the two groups are reported 
in Table 2. Mean score was 8.4 ± 1.3 for the responder group and 3.5 ± 1.5 for the non-responder group (P < 
0.001).  
 
Prediction of post-operative analgesia Group-wise analysis 
Clinical variables 
Clinical and demographic characteristics, pain medications and QST results stratified on responders and non-
responders are reported in Table 2. Chronic pain grade (P = 0.007) and MPSS stage (P = 0.01) were 
associated with the postoperative analgesic response groups. Non-responders predominantly belonged to 
more severe chronic pain grades (III and IV) and were skewed towards MPSS stage III (high pain 
chronicity). Furthermore, responders experienced more pain during the hip rotation test compared to the non-
responders (P = 0.03). In contrast, none of the QST parameters were associated with post-operative analgesia 
response (all P > 0.1). Results from the multivariate analysis (Table 3) revealed that only the chronic pain 
grade (P = 0.02) remained an independent predictor of postoperative analgesic response and the association 
remained significant after internal bootstrapping validation. Using the chronic pain grade to classify patients 
into response groups (Responders: Grade I and II and non-responders: Grade III and IV) yielded an accuracy 
of 63% (positive predictive value = 81%; negative predictive value = 50%). 
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 Resting EEG 
No differences in resting EEG were found between responders and non-responders for spectral EEG indices 
(all P > 0.1) or functional EEG connectivity (PLI) (all P > 0.1). The topographical plots are shown in Figure 
2 for the spectral indices and functional connectivity in Figure 3. 
 
EEG during cold pain 
There were no differences in spectral EEG indices (all P > 0.3) or functional connectivity (all P >= 0.1) 
between responders and non-responders during cold pain. The topographical illustration of the EEG spectral 
indices for responders and non-responders is shown in Figure 4 while the topography of the functional 
connectivity is illustrated in Figure 5. 
 Individual subject analysis (machine learning) 
Resting EEG 
Machine learning analysis was unable to distinguish between responders and non-responders with any 
number of resting EEG features (spectral EEG indices and functional connectivity) (maximum accuracy = 
58%; P = 0.2).   
 
EEG during cold pain 
Machine learning analysis discriminated between responders and non-responders when selecting features 
freely from both spectral indices and functional connectivity measures derived from the EEG. The most 
accurate classification was achieved using only one feature from the entire dataset. This was the delta 
spectral index band from frontally placed FP1 electrode with an accuracy of 65 % (positive predictive value 
= 76%; negative predictive value = 53%; P = 0.009).   
To ensure that the results were not related to the stratification of subjects, the analysis was also repeated by 
stratification based on opioid consumption within the first 24 hours after surgery. The cut-off value for 
opioid consumption was set at 65 mg morphine equivalent units, resulting in 45 patients in the high dose 
opioid group (i.e. > 65 mg morphine) and 37 patients in the low dose opioid group. Here it was not possible 





This study aimed to investigate response to post-operative analgesic treatment with opioids and investigate 
factors associated with insufficient response. Severity of the pre-surgical chronic pain condition was a factor 
associated with post-surgical insufficiency of analgesic treatment, while QST measures were not related. In a 
first for clinical studies, it was possible to predict analgesic efficacy based on the pre-operative EEG 
recordings using machine learning, with similar accuracy to the chronic pain grade. In line with previous 
research, tonic painful EEG proved to be useful in contrast to resting EEG for prediction  of opioid analgesia 
(Gram et al., 2015).  
 
Methodological considerations 
For a measurement to be of value within personalized medicine, reliability over longer time periods is a 
requirement (Bruton et al., 2000; Cannon et al., 2012). This study used spectral analysis and PLI of EEG 
during both rest and tonic cold pain, which are reliable, and therefore useful as a biomarker for prediction of 
analgesic efficacy (Gram et al., 2014; Hardmeier et al., 2014).  
The only previous study on prediction of analgesic effect of opioids using EEG was performed on healthy 
volunteers using an experimental pain model (Gram et al., 2015). The current study is clinical and as such, 
suffers from confounders such as anxiety, and existing medication (Olesen et al., 2012). Firstly, patients 
were suffering from preoperative chronic pain, which influences EEG (Olesen et al., 2011; Sarnthein et al., 
2006). Secondly, patients were already on analgesics before inclusion, which could also affect the EEG 
(Malver et al., 2014). Since pre-existing analgesic use could not be controlled for, this might have interfered 
with classification accuracy. On the other hand, since there was no difference in premedication analgesics 
between the groups and pre-operative opioid doses were low this is likely not of major importance. Lastly, 
the pain evoked in experimental pain models in our previous study is standardized between subjects, whereas 
the post-surgical pain is not, even when using a standardized operative procedure. Although the procedure is 
the same for all patients, there will always be variation in duration and complexity during surgery, which 
might affect postoperative pain. All these factors could explain why classification accuracy was lower in this 
clinical study. 
It was not possible to distinguish between responders and non-responders based on the resting EEG which is 
in line with previous research in where the tonic painful EEG was found superior to resting EEG for 
prediction of analgesic efficacy (Gram et al., 2015). Thus, it seems that the predictive biomarkers in the EEG 
are only present when subjects experience pain. Previously, tonic pain was shown to result in increases in the 
delta band, with a simultaneous suppression of the alpha band. This was also seen in the current study, but to 
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a lesser degree than previously reported (Gram et al., 2014). The water temperature for the cold pressor test 
was higher than in previous studies (range=1-7 °C) (Mitchell et al., 2004). However, perceived pain during 
the cold pressor test (~6 NRS) was experienced as intense. It is therefore unlikely that water temperature 
alone accounts for low accuracy. However, future studies should attempt to use lower temperatures for the 
cold pressor test. 
Within recent years, the gamma band of the EEG has received increasing attention within pain research. 
While large components of the EEG signal in evoked brain potentials have been shown to be closely related 
to the saliency of the stimulus rather than pain per se (Iannetti et al., 2008), the gamma band contains 
features specifically associated with pain perception (Tiemann et al., 2015; Zhang et al., 2012). However, 
most research on the gamma band was done on evoked brain potentials, where potentials contaminated by 
noise are easily rejected unlike in continuous EEG signals. This study utilized the cold pressor test for 
evoking pain, since tonic pain models have been shown to more closely mimic the unpleasantness of chronic 
pain (Rainville et al., 1992). The cold pressor test introduces electromyography artifacts into the gamma 
band, due to wincing facial expressions that accompanies prolonged and unpleasant tonic pain (Dowman et 
al., 2008). Taken together, despite its potential relevance for pain, the gamma band was excluded in this 
analysis to avoid the noise from muscle activity which could potentially also affect the results.  
Patients were stratified into two groups based on a combined score of clinical pain ratings in order to account 
for problems associated with PCA, namely that both pain scores and analgesic consumption varies in a 
related way in the post-operative setting (Dai et al., 2013). Therefore, the identification of the optimal 
method of combining pain scores with analgesic consumption is a major focus point for research in analgesic 
studies (Dworkin et al., 2008; Turk et al., 2008). Attempts have been made to develop integrated scores 
which encompass both metrics (Silverman, O’Connor, & Brull, 1993), but no method has received 
widespread acceptance and their validity remains unknown (Grosen et al., 2013). The stratification based on 
clinical response from the QUIPS questionnaire resulted into a response rate of roughly 65% which is in line 
with this type of procedure (Maier et al., 2010). It could be argued that opioid consumption should have been 
incorporated into the response score. However, the fact that stratifying based on opioid consumption did not 
yield higher prediction accuracies indicates that the stratification method is not the main reason for the 
relatively low accuracy. 
It should also be noted that the opioid medication in this study consisted of a combination of piritramide and 
oxycodone, which might affect individual patients differently (Drewes et al., 2013). Therefore, several sub-
groups might exist within these two response groups, complicating stratification. However, it was not 
ethically feasible to alter the routine treatment in this study. To further investigate response or non-response 
to individual opioids, future studies could attempt to treat using only one opioid.  
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 Prediction of post-operative analgesia 
Clinical parameters relating to the pre-surgical pain state was associated with post-operative analgesia. 
Hence, a higher proportion of severe pre-surgical chronic pain grades were associated with poor post-
operative analgesia. This corresponds well to the literature which consistently shows pre-operative pain is a 
strong predictor of acute post-operative pain (Gerbershagen et al., 2010; Pinto et al., 2015; Sommer et al., 
2008). Since the responder score in this study is based on the post-operative pain ratings it follows that the 
pre-surgical pain would be related to this score.  
Several studies have investigated prediction of analgesia based on QST and some results have been 
promising (Grosen et al., 2013). Heat and cold pain was included in this study as QST predictors, and neither 
proved effective for prediction. This could be due to central sensitization in the patients, for which opioids 
have limited effect (Olesen et al., 2013b).  
A dysfunctional descending inhibition (as assessed by CPM paradigms) has previously been associated with 
development of post-operative pain in different clinical settings including pain after thoracic and 
gastrointestinal surgeries (Ip et al., 2009; Yarnitsky et al., 2008). Overall, the CPM effect in patients was 
weak in both responders and non-responders and this observation likely reflects a dysfunctional descending 
inhibition.  
Group-wise statistical analysis of the EEG data revealed no differences between responders and non-
responders, while machine learning was able to discriminate between responder groups at the individual 
patient level with an accuracy of 65%. This result is comparable to the predictive accuracy of chronic pain 
grade (63%), but is likely more robust as it is obtained with an objective method. The positive predictive 
value of EEG based classification was 76%. Hence, if patients had been treated according to the machine 
learning results based on preoperative EEG during cold pain, response rate to piritramide and oxycodone 
would have been 76% compared to the actual 65% response rate in this study. The remaining patients would 
have been treated with an alternative treatment, though only 53% were actually non-responders, meaning 
that there were a higher proportion of false negatives. However, in a personalized medicine scenario where 
the EEG and SVM model would be used to decide which patients to switch to secondary analgesic treatment 
the patients falsely classified as non-responders could still respond to the alternative treatment. Since this 
study included no alternative treatment the actual response rate in a personalized medicine scenario could not 
be determined. 
The relative delta content from a frontally placed electrode (FP1) was selected as the most discriminate 
feature. This is comparable with previous research in healthy volunteers where frontal delta activity was 
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mainly selected by a machine learning approach (Gram, Graversen, Olesen, & Drewes, 2015). However, in 
this study only one feature was selected in comparison to the previous 7 features.  
Conclusions 
The novel use of EEG in combination with machine learning allowed for discrimination between responders 
and non-responders to postoperative analgesic opioid treatment. This shows EEG to be a potential important 
part in personalized pain medicine, with the potential to reduce suffering and persistent postoperative pain. 
The use of EEG in daily clinical work is becoming more and more feasible with new devices emerging, 
offering drastically reduced mounting times while retaining the quality of recordings (Sami et al., 2016). 
Future studies should work towards optimization of the methods together with inclusion of more variables in 
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Table 1: Demographical and clinical characteristics of patients scheduled for total hip replacement. Since some patients had 
missing data, the percentage of patients is given in a separate column for each parameter.  
 
 
 Patients, n (% of 
total cohort) 
Age (years) 64.5 ± 12.5 81 (100 %) 
   
Male sex, n (%) 36 (44 %) 81 (100 %) 
   
BMI (kg/m2) 28.1 ± 5.0 79 (98 %) 
   
WOMAC  54.6 ± 18.3 65 (80 %) 
   
Hip-pain duration, n (%)  81 (100 %) 
- 0 – 6 months 12 (15 %)  
- 6 – 12 months 11 (14 %)  
- 1 – 2 years 19 (23 %)  
- 2 – 5 years 20 (25 %)  
- More than 5 years 19 (23 %)  
   
Chronic pain grade, n (%)  78 (96 %) 
- Grade I-II 32 (41 %)  
- Grade III-IV 46 (59 %)  
   
MPSS, n (%)  81 (100 %) 
- Stage I 34 (42 %)  
- Stage II 26 (32 %)  
- Stage III 21 (26 %)  
   
   
Preoperative MQS - non-opioids  5.1 ± 4.5 79 (98 %) 
   
Preoperative MQS - opioids  0.6 ± 1.6 81 (100 %) 
   
 
WOMAC = Western Ontario and McMaster Universities Osteoarthritis Index; MPSS = Mainz Pain Staging 
System; MQS = Medication Quantification Scale.  
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Table 2: Baseline parameters for the included patients, divided into groups of responders (N = 51) and non-responders (N = 






(N = 51) 
Non-responders 
(N = 30) 
OR (95% CI) P-value 
Age (years)  64.2 ± 10.4 64.9 ± 15.7 1.05 (0.73-
1.51) 
0.81 
      
Male sex, n (%)  25 (49%) 11 (37%) 0.60 (0.24-
1.52) 
0.28 
      
BMI (kg/m2)  28.1 ± 4.6 28.1 ± 5.7 1.00 (0.91-
1.09) 
0.98 
      
WOMAC   51.6 ± 18.9 60.0 ± 16.2 1.03 (1.00-
1.06) 
0.082 
      
Hip-pain duration, n (%)      
- 0 – 6 months  7 (14%) 5 (17%) 1.00  
- 6 – 12 months  8 (16%) 3 (10%) 0.53 (0.10-
3.03) 
0.47 
- 1 – 2 years  12 (24%) 7 (23%) 0.82 (0.19-
3.58) 
0.79 
- 2 – 5 years  13 (25%) 7 (23%) 0.75 (0.17-
3.28) 
0.71 
- More than 5 years  11 (22%) 8 (27%) 1.02 (0.24-
4.41) 
0.98 
      
Chronic pain grade, n (%)      
- Grade I-II  26(53%) 6 (21%) 1.00  
- Grade III-IV  23 (47%) 23 (79%) 4.33 (1.50-
12.50) 
0.007 a 
      
MPSS, n (%)      
- Stage I  25 (49%) 9 (30%) 1.00  
- Stage II  18 (35%) 8 (27%) 1.23 (0.40-
3.82) 
0.71 
- Stage III  8 (16%) 13 (43%) 4.51 (1.41-
14.46) 
0.011 a 
      
Pain on hip rotation (NRS)  5.2 ± 2.0 6.2 ± 1.9 1.33 (1.02-
1.72) 
0.034 a 
      
Preoperative MQS - non-
opioids  
 4.6 ± 4.6 5.9 ± 4.3 1.06 (0.96-
1.18) 
0.24 
      
Preoperative MQS - opioids   0.4 ± 1.3 0.8 ± 1.9 1.14 (0.86-
1.52) 
0.36 
      
Post-surgery patient 
controlled analgesia - opioid 






      
Cold pressor pain (NRS)  6.1 ± 2.3 6.9 ± 2.5 1.16 (0.94-
1.42) 
0.17 
      
Heat pain threshold (°C)  47.0 ± 2.9 46.3 ± 3.7 0.93 (0.81-
1.07) 
0.34 
      
Pressure pain threshold (kPa)  71.7 ± 20.4 68.0 ± 22.2 1.01 (0.99-
1.03) 
0.45 
      
Conditioned pain modulation 
(%) 
 2.8 ± 4.3 2.8 ± 4.2 1.00 (0.90-
1.12) 
0.96 
a P < 0.05 
BMI = Body Mass Index; WOMAC = Western Ontario and McMaster Universities Osteoarthritis Index; 
MPSS = Mainz pain staging system; NRS = Numerical Rating Scale; OE = Opioid equivalent units; MQS = 
Medication Quantification Score. 
Table 3: Multivariate analysis of risk factors associated with inadequate post-operative analgesia identified using logistic 
regression. Internal validation performed with 1000 bootstrap samples. 
 
 
Multivariate analysis Internal validation 
 OR (95% CI) P-value OR (95% CI) P-value 
Chronic pain grade, n (%)     
- Grade I-II 1.00    
- Grade III-IV 3.74 (1.21-11.53) 0.022 a 3.74 (1.07-13.14) 0.04 a 
     
MPSS, n (%)     
- Stage I 1.00    
- Stage II 1.14 (0.34-3.83) 0.83   
- Stage III 1.99 (0.54-7.30) 0.30   
     
Pain on hip rotation (NRS) 1.26 (0.95-1.68) 0.11   
 
a P < 0.05 




Figure 1: Experimental setup and study procedures. PCA = Patient-Controlled Anaesthesia; QST = Quantitative Sensory 
Testing. 
Figure 2: Topographical illustration of the spectral indices calculated from the resting EEG in the four frequency bands; 
delta (1-4 Hz), theta (4-8 Hz), alpha (8-12 Hz) and beta (12-32 Hz). Activity is color coded with higher levels of activity 
represented in red and yellow colors, while lower activity is represented by blue. Responders to opioid treatment appear to 
have slightly decreased alpha activity, and increased beta activity. 
Figure 3: Topographical illustration of the phase-lag index calculated from the resting EEG in the four frequency bands. The 
color code shows red and yellow for electrodes that have stronger average connections to all other electrodes, while blue 
colors represent electrodes, which are poorly connected. Responders to opioid treatment appear to exhibit decreased 
connectivity of the alpha band compared to non-responders. 
Figure 4: Topographical illustration of the spectral indices calculated from EEG during cold pain, in the four frequency 
bands. Activity is color coded with higher levels of activity represented in red and yellow colors, while lower activity is 
represented by blue. Increased delta activity appears to be present for responders to opioid treatment. 
Figure 5: Topographical illustration of the phase-lag index calculated from the EEG during cold pain, in the four frequency 
bands. The color code shows red and yellow for electrodes that have stronger average connections to all other electrodes, 
while blue colors represent electrodes, which are poorly connected. Responders to opioid treatment seems to present with 
increased connectivity in the delta and theta bands compared to non-responders.  
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